Bremelanotide in Laboratory Research
A Synthetic Cyclic Heptapeptide for Melanocortin Receptor Investigation
Bremelanotide is a synthetic cyclic heptapeptide that has garnered significant attention in basic research for its interaction with melanocortin receptors (MCRs). Its amino acid sequence—Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH—creates a constrained lactam bridge between the aspartic acid and lysine side chains, yielding a molecule with notable stability and receptor affinity. In vitro and in vivo laboratory models commonly employ bremelanotide to probe the physiological roles of the MC1R, MC3R, MC4R, and MC5R subtypes. Binding assays and functional cAMP accumulation studies using recombinant cell lines reveal that bremelanotide acts as a potent agonist at several of these receptors, a feature that makes it a valuable tool compound for dissecting signaling pathways.
Key research applications include investigations into central energy homeostasis and reproductive behavior. Rodent models administered bremelanotide via intracerebroventricular or peripheral routes have shown alterations in food intake and body weight regulation, primarily through MC4R activation. Simultaneously, studies on female sexual receptivity—such as lordosis behavior in ovariectomized rats—indicate involvement of MC3R and MC4R, providing insights into the neuropeptide circuitry that coordinates reproduction and metabolic state. Researchers rely on pure and fully characterized peptide to ensure reproducible data. When sourcing bremelanotide, many laboratories seek a bremelanotide supplier with COA to verify peptide identity and purity, reducing experimental variability.
Purity and Identity – Foundations of Reliable Data
The integrity of laboratory findings hinges on the quality of the test substance. Bremelanotide produced for research must meet stringent acceptance criteria. A batch-specific Certificate of Analysis (COA) confirms that the peptide’s actual molecular mass, determined by mass spectrometry (MS), matches the theoretical value within a very narrow tolerance. High-performance liquid chromatography (HPLC) analysis provides a purity profile, typically expressed as area percent, with a common specification of ≥95% purity at 214 nm. Impurities such as deletion sequences or oxidation products are minimized to levels that do not interfere with assay readouts. The COA also reports net peptide content, a correction factor essential for preparing accurate stock solutions in receptor binding or cell-based assays. Without such verification, a peptide might contain unquantified salts or water, leading to erroneous molar calculations and conflicting results across experiments. Thus, engaging a bremelanotide supplier with COA that provides comprehensive analytical data is a critical step in safeguarding the reproducibility of preclinical research.
Certificate of Analysis for Research Peptides
Documenting Identity Through Mass Spectrometry and Purity via HPLC
A Certificate of Analysis is the definitive record of a research peptide’s quality parameters for a specific production batch. At its core, the COA provides two fundamental pieces of analytical evidence: the molecular identity and the chromatographic purity. Identity is usually confirmed by electrospray ionization (ESI) or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. The resulting spectrum displays a prominent ion peak corresponding to the singly or multiply charged peptide; the deconvoluted mass must align with the calculated monoisotopic or average mass. Purity is assessed by reverse-phase HPLC, where the main product peak is integrated and compared against any minor impurity peaks. An exemplar COA will include a chromatogram with retention time, peak area percentages, and gradient conditions, enabling the researcher to gauge the extent of closely related impurities.
Net Peptide Content and Counterion Information
Beyond purity and identity, a thorough COA quantifies the peptide’s net content, which reflects the proportion of peptide material relative to the total weight of the lyophilized powder. This value accounts for residual water, counterions (commonly trifluoroacetate, TFA, or acetate), and other non-peptide components. Typical net peptide content for a research-grade product ranges from 65% to 85%, depending on the purification and lyophilization protocol. Accurate determination is performed through amino acid analysis or nitrogen elemental analysis, and the result allows researchers to calculate the actual peptide concentration in reconstituted solutions. The COA also specifies the counterion type and concentration, information that can be critical for cell-based assays where excess TFA might affect cell viability. For long-term studies, batch-to-batch consistency in counterion profile and net content is vital; reviewing the COAs from a trusted bremelanotide supplier with COA ensures that each new batch behaves predictably in established assay systems.
Enabling Cross-Batch Consistency and Documentation
Archival of COAs for each received shipment forms part of good laboratory practice. When a peptide is used across multiple experimental cohorts or by different team members, the COA serves as a traceable reference that any observed shift in results is not due to material variability. Many research institutions now require that COAs be attached to laboratory notebooks or uploaded to electronic data management platforms. A supplier that consistently issues detailed, shipment-specific COAs demonstrates a commitment to transparency, which in turn supports the integrity of published research. Investigators who compile data for peer-reviewed manuscripts can cite the peptide’s lot-specific purity and identity, strengthening the materials and methods section.
Evaluating a Bremelanotide Supplier
Shipment-Specific COA as a Non-Negotiable Quality Gate
An immediate indicator of a reliable supplier is the routine inclusion of a batch- and shipment-specific COA with every order. Unlike a generic or placeholder certificate that simply restates typical specifications, a genuine COA is linked to the actual lot number shipped, reflecting current analytical test results. This documentation is particularly important for bremelanotide, a product that may be synthesized in multiple campaign batches and subjected to different purification runs. A bremelanotide supplier with COA that provides this level of traceability empowers the receiving laboratory to verify that the product meets its research requirements before any experiments begin. If a COA is absent, incomplete, or appears to be photocopied without lot-specific data, this raises questions about the supplier’s quality system and their ability to guarantee consistent product specifications.
Expertise in Peptide Synthesis and Purification
The credibility of a peptide supplier is built on demonstrated technical competence. For a cyclic heptapeptide like bremelanotide, the synthesis involves solid-phase peptide assembly using Fmoc chemistry, on-resin cyclization (typically through Asp-Lys side-chain lactam formation), and cleavage from the resin while maintaining side-chain protecting groups. Post-cleavage, preparative HPLC purification is required to isolate the target product from truncated, deleted, or epimerized impurities. A knowledgeable supplier can discuss these steps and share details of their purification strategy, such as the use of C18 or C4 stationary phases, step gradients, and the rationale for counterion exchange if an acetate salt is preferred. They should be able to explain how they address common challenges, such as aspartimide formation or incomplete cyclization. Additionally, in-house manufacturing facilities that operate under documented quality systems—often aligned with standards like ISO 9001—provide an added layer of assurance.
Transparency and Availability of Raw Analytical Data
A supplier that goes beyond the summarized COA and offers access to raw or semi-raw data gains trust. For example, upon request, a transparent supplier may provide the full HPLC chromatogram with baseline integration, the MS spectrum with isotopic envelope, or the amino acid analysis report. Such openness allows researchers to perform their own validation or to satisfy the documentation requirements of institutional review boards and grant auditors. Responsiveness to technical inquiries—such as questions about the interpretation of counterion data or the suitability of storage conditions—further distinguishes a supplier that views itself as a partner in research. When evaluating potential sources, academic and industry scientists alike prioritize suppliers that make analytical information readily accessible, as this reduces the burden of independent quality control testing.
Quality Control in Peptide Manufacturing
Documented SOPs and Raw Material Testing
Consistent peptide quality begins well before the first amino acid is coupled to the resin. Robust manufacturers operate according to written standard operating procedures (SOPs) that govern every phase of production, from receipt of raw materials to final packaging. All incoming amino acid derivatives, resins, coupling reagents, and solvents undergo identity and purity testing. This may involve melting point determination, optical rotation, thin-layer chromatography, and HPLC-MS of activated amino acids. Only materials meeting pre-defined acceptance criteria are released for synthesis. During the solid-phase assembly, real-time monitoring—via Kaiser or chloranil tests—confirms complete coupling at each cycle, while periodic microcleavage and MS analysis can detect sequence errors early. These practices minimize the occurrence of deletion or truncation byproducts that would otherwise burden downstream purification.
Comprehensive Analysis of Finished Products
Before a lyophilized batch of bremelanotide is approved for release, it undergoes a battery of analytical tests. The following assessments are typically performed, as reflected in a comprehensive COA:
- Appearance: Visual inspection to confirm a white to off-white lyophilized powder, free of foreign particulate.
- Solubility: A predefined concentration is tested in a standard solvent (e.g., water or DMSO) to ensure complete dissolution without turbidity.
- Purity by HPLC: Area percent determination at 214 nm, with a typical specification of ≥95.0%.
- Identity by MS: The observed mass-to-charge ratio(s) must correspond to the calculated molecular mass within an acceptable error tolerance (e.g., ±0.5 Da for ESI-MS).
- Peptide Content: Determined by amino acid analysis or elemental analysis, reported as a percentage by weight.
- Counterion Content: Quantified by ion chromatography or capillary electrophoresis, if relevant to the salt form supplied.
- Residual Solvents: Gas chromatography checks for manufacturing solvents (e.g., acetonitrile, dichloromethane) per pharmacopoeia guidelines, ensuring they remain below safety thresholds.
For certain research applications, additional tests such as bacterial endotoxin measurement (LAL test) or bioburden assessment may be requested. The release process also includes a review of packaging integrity and labeling accuracy. At each stage, the data are compared against product-specific specifications, and any deviation triggers an investigation. This multi-layered approach is what allows a bremelanotide supplier with COA to deliver a product that scientists can confidently incorporate into their experimental workflows.
Logistics and Handling of Peptide Research Compounds
Temperature-Controlled Storage and Shipping
Peptides, particularly those with labile functional groups or substantial hydrophobic character, are susceptible to degradation via hydrolysis, oxidation, or aggregation. Bremelanotide, supplied as a lyophilized solid, is chemically stable when stored at -20°C or below, protected from moisture and light. During transportation, a validated cold chain is essential. Domestic shipments typically use insulated containers with gel ice packs to maintain a temperature of 4°C or below for 24–72 hours. International orders may require dry ice to ensure the peptide remains in a deep-frozen state during extended transit. Upon receipt, the research team should immediately transfer the vials to the recommended storage freezer and record the storage start date. After reconstitution in an appropriate solvent, bremelanotide stock solutions should be aliquoted and kept at -80°C to avoid repeated freeze-thaw cycles that can accelerate peptide degradation.
Documentation Accompanying Each Order
In addition to the COA, a compliant shipment of a research peptide will include a material safety data sheet (MSDS)/safety data sheet (SDS). This document outlines hazard identification, handling precautions, first-aid measures, and spill containment procedures, fulfilling occupational health and safety requirements. For international orders destined for universities, institutes, or pharmaceutical laboratories, the package will contain a commercial invoice and possibly a declaration that the contents are for laboratory research only, without any commercial or diagnostic application. These documents are essential for customs processing and help prevent clearance delays. A bremelanotide supplier with COA that proactively provides accurate and complete paperwork reduces the administrative burden on the receiving institution.
Customs Clearance Assistance for International Shipments
Shipping peptide research compounds across borders involves navigating diverse import regulations. Experienced suppliers assist by classifying the material with appropriate Harmonized System (HS) codes, attaching the required certifications (such as a certificate of origin or a statement of no commercial value), and communicating with the consignee’s customs broker. They may also provide a letter of authorization or a technical description letter explaining the nature of the product in sufficient detail to satisfy regulatory queries. While the ultimate responsibility for import compliance rests with the recipient, a supplier’s support infrastructure—including a logistics team knowledgeable about restrictions on biochemical imports—can significantly smooth the process. For repeat customers, streamlined documentation reduces transit time, helping ensure that critical research timelines are met. It is important that all parties understand the product is supplied exclusively for in vitro research and is not destined for human or veterinary application.
Research Use Only
All products discussed in this article, including bremelanotide, are intended strictly for laboratory research purposes. They are not manufactured for use as active pharmaceutical ingredients, food additives, or diagnostic components. These substances have not been evaluated by regulatory agencies for safety or effectiveness in humans or animals. Their use must be confined to controlled, non-clinical experiments conducted by qualified professionals in accordance with all applicable laws and institutional guidelines.
Solo para uso en investigación. No apto para uso humano ni veterinario.
